In This Article:
As global markets navigate a choppy start to the year, with small-cap stocks underperforming and inflation concerns persisting, investors are closely watching economic indicators and policy shifts that could impact growth prospects. In this environment, identifying high-growth tech stocks requires careful consideration of factors like resilient business models and innovative potential that align with evolving market dynamics.
Top 10 High Growth Tech Companies
Name | Revenue Growth | Earnings Growth | Growth Rating |
---|---|---|---|
Ascelia Pharma | 76.15% | 47.16% | ★★★★★★ |
CD Projekt | 23.18% | 27.00% | ★★★★★★ |
Waystream Holding | 22.09% | 113.25% | ★★★★★★ |
AVITA Medical | 33.33% | 51.81% | ★★★★★★ |
Alkami Technology | 21.99% | 102.65% | ★★★★★★ |
Pharma Mar | 25.43% | 56.19% | ★★★★★★ |
Alnylam Pharmaceuticals | 21.39% | 56.40% | ★★★★★★ |
TG Therapeutics | 30.33% | 44.07% | ★★★★★★ |
Elliptic Laboratories | 70.09% | 111.37% | ★★★★★★ |
Travere Therapeutics | 29.92% | 61.97% | ★★★★★★ |
Click here to see the full list of 1224 stocks from our High Growth Tech and AI Stocks screener.
Here's a peek at a few of the choices from the screener.
Sectra
Simply Wall St Growth Rating: ★★★★★☆
Overview: Sectra AB (publ) is a company that offers solutions in the medical IT and cybersecurity sectors across Sweden, the United Kingdom, the Netherlands, and other parts of Europe, with a market capitalization of SEK47.95 billion.
Operations: Revenue primarily comes from Imaging IT Solutions, generating SEK2.61 billion, followed by Secure Communications at SEK425.85 million. The company's focus on medical IT and cybersecurity solutions is evident in its revenue distribution across these segments.
Sectra stands out in the digital healthcare tech landscape, notably with its recent expansion into digital pathology through a new contract with Helse Nord RHF. This move is set to enhance patient care by streamlining pathologists' workflows, indicative of Sectra's strategic push towards integrated medical solutions. Despite a slight dip in quarterly earnings as reported on December 12, 2024, with net income falling to SEK 87.76 million from SEK 150.56 million year-over-year, the company's commitment to innovation remains robust. The adoption of Sectra's enterprise imaging solutions by prominent healthcare providers like AZ Sint-Lucas Gent and MaineGeneral Health underscores its pivotal role in advancing medical diagnostics efficiency and security on a global scale.
-
Unlock comprehensive insights into our analysis of Sectra stock in this health report.
-
Explore historical data to track Sectra's performance over time in our Past section.
Shengyi Electronics
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Shengyi Electronics Co., Ltd. focuses on the research, development, production, and sales of various printed circuit boards in China with a market capitalization of CN¥31.97 billion.